Back to search results

Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Extensive-stage Small Cell Lung Cancer (ES-SCLC) · Extensive Stage Lung Small Cell Cancer · Extensive-Stage Small-Cell Lung Cancer · Extensive Disease Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China

    Contact: Study coordinator (Yongchang Zhang, MD, PhD) · zhangyongchang@csu.edu.cn · +8613873123436

  • Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong, China

    Contact: Study coordinator (Xiangjiao Meng, MD, PhD) · mengxiangjiao@sina.com · +8613793150996

  • Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Jing Qin, MD, PhD) · qinjing@zjcc.org.cn

  • First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Jian Ruan, MD, PhD) · software233@zju.edu.cn

  • Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Yang Xia, MD, PhD) · yxia@zju.edu.cn · +8618868439669
View source on ClinicalTrials.gov(opens in a new tab)